Clinical Evaluation of Two Monthly Contact Lenses

Inclusion criteria

• Able to understand and sign an approved informed consent form (ICF);
• Successful wear of BIOFINITY® (spherical) (or private label) contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months;
• Best-corrected visual acuity (BCVA) 20/25 or better in each eye;
• Possess spectacles that provide a corrected visual acuity of 20/40 or better in both eyes (OU) and be willing to wear them (as needed);
• Currently using digital devices (computer, tablet, and/or smart phone) for a minimum of 5 days per week and 4 hours per day;
• Other protocol-specified inclusion criteria may apply.

Exclusion criteria

• Any anterior segment infection, inflammation, abnormality or disease that contraindicates contact lens wear;
• Any use of systemic or ocular medications for which contact lens wear could be contraindicated;
• Refractive, ocular, or intraocular surgery, as specified in the protocol;
• Current or history of eye injury or disorders, as specified in the protocol;
• Current or history of intolerance, hypersensitivity or allergy to any component of the study products;
• Habitual contact lens wear in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment;
• Use of topical ocular medications that would require instillation during contact lens wear;
• Other protocol-specified exclusion criteria may apply.